Centre Hospitalier Universitaire De Dijon

At Centre Hospitalier Universitaire De Dijon, a major share of research focuses on neoplasms and related blood cancers. Trials are studying diseases such as melanoma, lymphoma, breast cancer, lung cancer, biliary tract cancer, and bladder cancer, with the goal of improving treatment effectiveness, reducing recurrence, and refining post-surgical care.

• Melanoma, including resected and advanced forms
• Classical Hodgkin lymphoma and marginal zone lymphoma
• Advanced biliary tract, colon, anal, and bladder cancers
• Studies testing new immunotherapy and combination treatment strategies

These studies reflect a strong interest in better cancer control, especially for patients with advanced or high-risk disease.

The site also conducts important work in cardiovascular diseases and blood clotting disorders. Research includes acute coronary syndrome, atrial fibrillation, stroke, venous thromboembolism, and broader atherosclerotic risk, with trials aimed at preventing major events and improving long-term protection.

• Stroke prevention after ischemic events or transient ischemic attack
• Atrial fibrillation and clot prevention
• Atherosclerotic cardiovascular risk and lipid-related disease
• Balancing anticoagulation benefits with bleeding risk

Much of this research is designed to help clinicians choose safer and more effective ways to prevent heart attacks, strokes, and clot-related complications.

Research in respiratory tract diseases and intensive care is another clear strength at this hospital. Trials cover COVID-19, community-acquired pneumonia, ventilator-associated pneumonia, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and other progressive lung conditions, often focusing on treatment benefit in hospital settings.

• COVID-19 treatment strategies in hospitalized patients
• Severe bacterial pneumonia and ventilator-associated pneumonia
• Progressive interstitial lung disease and pulmonary fibrosis
• Therapies intended to improve recovery and survival

This area combines infection management with chronic lung disease care, reflecting a broad respiratory research portfolio.

Clinical trials at the Dijon site also address skin and connective tissue diseases and immune system diseases. Key conditions include atopic dermatitis, psoriasis, hidradenitis suppurativa, prurigo nodularis, polymyalgia rheumatica, and Sjögren’s syndrome, with studies aimed at symptom control and better long-term disease management.

• Chronic inflammatory skin diseases such as atopic dermatitis and psoriasis
• Hidradenitis suppurativa and prurigo nodularis
• Autoimmune and inflammatory disorders including polymyalgia rheumatica and Sjögren’s syndrome
• Testing new therapies and treatment-sparing approaches

This research supports improved quality of life for patients living with persistent inflammatory conditions.

The department’s strong radiology and diagnostic imaging profile is reflected in trials on eye diseases and advanced imaging tools. Studies include glaucoma, macular edema, and imaging contrast evaluation, with the aim of preserving vision and improving diagnostic performance.

• Glaucoma and visual field preservation
• Macular edema linked to retinal vein occlusion
• Evaluation of new MRI contrast agents
• Research focused on better diagnosis and monitoring

These trials combine clinical eye care with imaging research, showing how the site links diagnosis and treatment innovation.

Another active area involves digestive system diseases and nutritional and metabolic disorders. Trials cover ulcerative colitis, hypertriglyceridemia, colon carcinoma, and biliary tract carcinoma, often aiming to improve disease control, reduce relapse, or support better post-treatment outcomes.

• Inflammatory bowel disease, especially ulcerative colitis
• High triglycerides and related cardiovascular risk
• Colon and biliary tract cancers after surgery or chemotherapy
• Studies evaluating maintenance treatment and recurrence prevention

These projects highlight a mix of cancer, digestive, and metabolic research with practical implications for everyday care.

Beyond its main specialties, the site contributes to trials in pathological conditions and broader clinical research, including intracerebral hemorrhage, preeclampsia, and pulmonary embolism. Some studies also involve healthy volunteers or imaging-related questions, supporting a wide-ranging research environment.

• Brain bleeding and stroke-related outcomes
• Pregnancy complications such as preeclampsia
• Pulmonary embolism and anticoagulation decisions
• Supportive research in imaging, prevention, and clinical surveillance

These trials show the breadth of clinical investigation at the Centre Hospitalier Universitaire De Dijon, extending well beyond one disease area.